NEW YORK (GenomeWeb News) – DiscoveRx said today that it will provide GlaxoSmithKline with cell lines and reagents for G-protein coupled receptor screening.

Under the worldwide pact, DiscoveRx, based in Fremont, Calif., will provide GSK with access to its PathHunter beta-arresting parental cell lines, clones, and associated reagents for use in GSK's internal GPCR screening and profiling efforts.

Financial terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.